# Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study

> **NCT07169019** · EARLY_PHASE1 · RECRUITING · sponsor: **Alexandria University** · enrollment: 24 (estimated)

## Conditions studied

- Psoriasis (PsO)

## Interventions

- **DRUG:** Probiotics and methotrexate
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT07169019
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-08-20
- **Final completion:** 2026-12-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169019, "Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07169019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*